Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pro Diagnostic Group is a Slovak healthcare company focused on radiology and nuclear medicine services rather than therapeutic drug development. The company operates a nationwide network of diagnostic imaging centers offering MRI, CT, ultrasound, SPECT, SPECT/CT, and PET/CT examinations, with centers placed in leading Slovak hospitals. It also uses supporting digital infrastructure including PACS connectivity, a teleradiology center, and physician-facing online tools to streamline image review and reporting. In nuclear medicine, the group highlights advanced PET/CT capabilities and use of radiopharmaceuticals such as 11C-methionine and 18F-choline for specific oncology applications. Based on available information, Pro Diagnostic Group is an active commercial healthcare services company and not a biotech or pharma pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pro Diagnostics Group.